Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
23 Mar 2018 FDA Approves Brentuximab Vedotin for Previously Untreated Stage III or IV Classical Hodgkin Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
22 Mar 2018 Substantial Genomic Heterogeneity Characterises TNBC Molecular Subtypes Translational research
21 Mar 2018 Immune-Modified Response Criteria in Solid Tumours Cancer Immunology and Immunotherapy
20 Mar 2018 Social Network Index Developed to Assess the Support Resources of Adolescent and Young Adult Cancer Survivors Cancer in Special Situations
19 Mar 2018 Metastatic Prostate Cancer Project Explores a New Approach to Genomics Research Genitourinary cancers - Translational research
16 Mar 2018 EMA Recommends Extension of Therapeutic Indications for Denosumab Palliative and supportive care
16 Mar 2018 EMA Recommends Extension of Therapeutic Indications for Denosumab Palliative and supportive care
15 Mar 2018 Patient-Derived Organoids Can Recapitulate Patient Responses in the Clinic Gastrointestinal cancers - Translational research
14 Mar 2018 Depression Treatment Does Not Improve the Survival of Depressed Patients with Cancer Palliative and supportive care
13 Mar 2018 EMA Recommends Contraindication for the Use of the Prostate Cancer Medicine Radium-223 Dichloride with Abiraterone Acetate and Prednisone/Prednisolone Genitourinary cancers - Anticancer agents & Biologic therapy
12 Mar 2018 Withdrawal of Application for a Change to the EU Marketing Authorisation for Idelalisib Haematologic malignancies - Anticancer agents & Biologic therapy
09 Mar 2018 EMA Recommends Extensions of Therapeutic Indications for Bosutinib Haematologic malignancies - Anticancer agents & Biologic therapy
08 Mar 2018 Multidisciplinary Team Care is Associated with Improved Survival in Metastatic GCT Genitourinary cancers
07 Mar 2018 NICE Issues an Advice on Chemotherapy Dose Standardisation Anticancer agents & Biologic therapy
06 Mar 2018 EMA Recommends Granting a Marketing Authorisation for Gemtuzumab Ozogamicin Haematologic malignancies - Anticancer agents & Biologic therapy